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Abstract 
Evidence from randomised controlled trials supports beneficial effects of total dairy products on 
body weight, fat and lean mass, but evidence on associations of dairy types with distributions of 
body fat and lean mass is limited. We aimed to investigate associations of total and different types 
of dairy products with markers of adiposity, and body fat and lean mass distribution. We evaluated 
cross-sectional data from 12,065 adults aged 30 to 65 years recruited to the Fenland study between 
2005 and 2015 in Cambridgeshire UK. Diet was assessed with a food frequency questionnaire. We 
estimated regression coefficients (or % differences) and their 95% CI using multiple linear 
regression models. The median (interquartile range) of milk, yoghurt, and cheese consumption were 
293 (146 - 439), 35.3 (8.8 – 71.8), and 14.6 (4.8 – 26.9) g/d, respectively. Low-fat dairy 
consumption was inversely associated with visceral-to-subcutaneous fat ratio estimated with dual 
energy X-ray absorptiometry [-2.58% (-3.91, -1.23%) per serving/day]. Habitual consumption per 
serving/day (200 g) of milk was associated with 0.33 (0.19, 0.46) kg higher lean mass. Other 
associations were not significant after false discovery correction. Our findings suggest that the 
influence of milk consumption on lean mass and of low-fat dairy consumption on fat mass 
distribution may be potential pathways for the link between dairy consumption and metabolic risk. 
Our cross-sectional findings warrant further research in prospective and experimental studies in 
diverse populations. 
Introduction 
Diet is acknowledged to be a leading behavioural risk factor for cardio-metabolic diseases(1). 
Among dietary factors, dairy products are of particular interest due to their inverse association with 
cardio-metabolic health(2), thought to be related to their high nutrient density and mineral content, 
but also due to the controversy arising from their blood cholesterol raising saturated fat content(3). 
Several meta-analyses of prospective cohort studies on the associations of dairy products with 
cardiovascular disease(4, 5) and type 2 diabetes(6-8) have suggested that the associations vary by 
dairy type. There is a general concordance of observational results suggesting an inverse association 
between yoghurt consumption and type 2 diabetes(6-8). In contrast, evidence for associations 
between other dairy types and type 2 diabetes(7, 9) or cardiovascular disease(4) is inconsistent with 
either null or inverse associations reported for the consumption of cheese and low-fat milk(4, 7, 9). 
Adiposity is one of the most well described potential pathways which might link total dairy 
consumption to cardio-metabolic disease pathogenesis. Evidence from randomised clinical trials 
shows that total dairy products decrease body weight(10) and body fat mass(10), and increase body 
lean mass(11) under energy restriction. However, evidence on associations between types of dairy 
products and markers of adiposity, especially markers of fat and lean mass distribution is sparse. 
Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SCAT) are compartments of 
abdominal fat. While abdominal fat is associated with cardio-metabolic diseases(12), VAT has been 
more strongly associated with cardio-metabolic risk than SCAT(13), which has been suggested to 
be potentially protective(14). Specifically the ratio of VAT to SCAT was reported to be strongly 
associated with cardio-metabolic risk independent of body mass index (BMI) and VAT(15). Due to 
the higher cost of the methods to estimate abdominal fat distribution e.g. dual energy X-ray 
absorptiometry (DEXA), most large-scale population studies examine waist circumference as a 
proxy for abdominal fat, which cannot fully capture the distribution between VAT and SCAT. Only 
a few studies have investigated associations between dairy products (total(16) and low-fat(17)) and 
VAT, but evidence is lacking on associations of dairy consumption with SCAT and VAT/SCAT.  
We aimed to investigate the associations of total and different types of dairy products with body fat 
and lean mass and their distribution in a large population-based study in the UK. 
Methods 
Study design and population 
The Fenland study is a cohort study with baseline measurements conducted between 2005 and 2015 
(n=12,434 with 27% response rate). Eligible participants were born between 1950 and 1975 and 
were invited via their general practice to attend the clinical sites at Ely, Wisbech, or Cambridge, 
UK, where the clinical and dietary assessments were conducted. Exclusion criteria, assessed by 
general practitioners, were known history of diabetes, psychotic or terminal illness, inability to walk 
unaided, pregnancy, or lactation. The study was approved by the Cambridge Local Ethics 
Committee. All participants gave written informed consent. 
For the current analysis, we evaluated baseline data from 12,065 participants after exclusion of 
pregnant women (n=5), participants with missing dietary data (n=17), those in the bottom and top 
1% of total energy intake (n=250), and in the top 1% of total dairy consumption (n=97). 
Participants with missing outcome data were also excluded (n range=1-812 depending on the 
outcome). A study flowchart of participant inclusion is presented in Figure 1. 
Dietary assessment 
Participants’ diet over the previous year was assessed with a 130-item semi-quantitative food 
frequency questionnaire(18). The dietary data were processed using FETA software(19). Dairy 
products were assessed in servings/d and were categorised as we previously described(20) (Table 
1). Dairy servings were defined as one average glass (200 g) for milk, 125 g pot for yoghurt, a 
medium serving of 40 g for cheese, one tablespoon (15 g) for single cream, one tablespoon (30 g) 
for double cream, one teaspoon (10 g) for butter and one average scoop/tub (60 g) for ice-cream.  
Adiposity measures 
These measurements were conducted at each clinical site according to standardised procedures. 
BMI was calculated as weight divided by height squared (kg /m
2
). Waist and hip circumferences 
were averaged from two repeated measures with a non-stretch tape. Total body fat and its 
distribution (peripheral fat, VAT, SCAT) and lean mass and its distribution (appendicular lean 
mass) were estimated with a DEXA scan (Lunar Prodigy Advanced fan beam scanner, GE 
Healthcare, Bedford, United Kingdom; GE encore software, version 14.10.022 to 16, GE Medical 
Systems(21)). Specifically, the DEXA system demarcated the boundaries of the android region 
based on an established protocol. VAT was estimated as part of the android region from an inbuilt 
algorithm of the DEXA software. SCAT was calculated after subtracting VAT from the android fat 
mass. These DEXA estimates of abdominal VAT and SCAT have been validated against amounts 
of VAT and SCAT determined by computed tomography(22) and magnetic resonance imaging(23), 
the reference methods for adipose tissue quantification.  
Assessment of socio-demographic and lifestyle factors 
A general questionnaire was administered for information on ethnicity, occupation, education, 
income, marital status, smoking and medication use. Physical activity was objectively measured 
over 7 d using a combined heart rate and movement sensor (Actiheart, CamNtech, Papworth, 
UK)(24) and individually calibrated with a treadmill test to derive physical activity energy 
expenditure (kJ/kg per d)(25). This method was previously validated with doubly-labelled water. 
Statistical analyses 
As primary exposures, we considered milk, yoghurt and cheese. As primary outcome, we defined 
the ratio of VAT to SCAT (VAT/SCAT). Other outcomes included total and peripheral body fat 
mass, total and appendicular body lean mass and proxies of abdominal fat i.e. waist circumference 
and the waist-to-hip ratio. We presented results for VAT/SCAT as %change after back-
transformation (exponentiation) of the log-transformed variable, because it was positively-skewed. 
Missing covariates were imputed by chained equations under the assumption of data missing at 
random(26). Multiple imputation involved linear, logistic and predictive mean matching models 
according to variable distribution and five imputation datasets were derived. Further analyses 
accounted for variability due to imputation. To examine cross-sectional associations between 
different dairy types and adiposity markers, robust multiple linear regression was used, deriving 
multiple maximum likelihood (MM-)estimators, which are robust against the influence of 
outliers(27). The initial probability of false positive findings was set to 5%. Because of the large 
number of tests, false discovery rate correction was applied accounting for correlations between 
tests(28). Associations were considered significant if they passed this correction (P<0.0005). 
Associations were adjusted for potential confounders based on previous knowledge and biological 
plausibility. Specifically, we adjusted for socio-demographic, lifestyle and clinical factors including 
age, sex, test-site, ethnicity, age at completion of full-time education, education level, occupation, 
household income, marital status, smoking status, pack-years of smoking, physical activity energy 
expenditure, hormone-replacement therapy (for women only), lipid-lowering medication, anti-
hypertensive medication (categorical), plasma vitamin C (as a marker of diet quality, reflecting fruit 
and vegetable intake), dietary supplement use, total energy intake, consumption of dietary factors 
(fruit, vegetables not including potatoes, potatoes, legumes, processed cereals, whole-grain cereals, 
poultry and eggs, red meat, processed meat, fish, sauces, margarine, nuts, sweet snacks, sugar-
sweetened beverages, artificially sweetened beverages, fruit juice, regular coffee, decaffeinated 
coffee, tea, alcoholic beverages), and BMI. Adjustment for BMI was performed to (1) examine 
associations independent of BMI, (2) partly account for the possibility of dietary misreporting and 
(3) account for lifestyle confounding due to obesity status. Dairy types were mutually adjusted. 
When the outcome was lean mass, models were further adjusted for height. 
Pre-specified tests for effect modification by sex and BMI for each association were investigated. 
As sensitivity analyses, we repeated regression analyses in the complete-case dataset, to examine 
stability of results based on five imputed datasets in the primary analyses. To assess whether non-
linear associations were present, restricted cubic spline regressions (three knots at the 10
th
, 50
th
 and 
90
th
 percentiles) were fitted in the most adjusted model above. For the same purpose, categorical 
exposures were used with five categories including non-consumers and quartiles among consumers 
for types of dairy products. Quartiles were generated from the residuals of the regression of total 
energy intake against dairy products(29). In addition to the analyses including BMI as a covariate, 
we also adjusted for the ratio of total energy intake to basal metabolic rate as an indicator of dietary 
misreporting(30). In post-hoc analyses, we examined whether the identified significant associations 
can be explained by nutrients contained in dairy products including calcium, potassium, 
magnesium, phosphorus, vitamin A, vitamin B12, lactose, mono-unsaturated fat and saturated fat 
from the dairy exposure one-by-one. All analyses were conducted using Stata 14.2 (College Station, 
TX: StataCorp LP, 2015). 
Results 
Descriptive characteristics 
We evaluated 12,065 adults (53.8% women) with a mean (SD) age of 48.8 (7.5) years (Table 2). 
Almost two-thirds of high yoghurt consumers were women. Participants of non-white ethnic 
background were more frequently low dairy consumers compared with participants of white ethnic 
background. The ethnic difference was most marked for cheese intake: the percentage of non-white 
participants among non-consumers of cheese was 6.3% higher than among cheese consumers. 
Yoghurt and cheese consumption was positively associated with higher socio-economic status and 
negatively associated with likelihood of being current smokers (Supplemental Table 1). Among 
dairy consumption levels, overall, low-fat dairy consumption was approximately seven times higher 
than that of high-fat dairy (Supplemental Table 1).  
Dairy products and body composition 
Habitual milk consumption was significantly associated with higher BMI; each additional serving 
of milk/d was associated with 0.26 (95% CI: 0.16, 0.36) kg/ m
2
 higher BMI (Supplemental Table
2). Similar associations were observed for low-fat milk and for low-fat and total dairy products. 
Low-fat dairy consumption was associated with 2.6% lower (-3.91, -1.23%) VAT/SCAT. A similar 
association was observed for VAT (Supplemental Figure 1).  
Habitual milk consumption was significantly associated with 0.33 (0.19, 0.46) kg higher lean mass 
per serving/d (Figure 2). Low-fat milk showed similar associations (Figure 2). The association was 
partly attenuated when adjusted for height, but it was still significant [0.18(0.10, 0.27) kg/serving of 
milk/d]. Effect modification by BMI was suggested for the association between high-fat dairy and 
appendicular lean mass (P-interaction=0.0001). Among adults with non-overweight BMI (<25 
kg/m
2
), appendicular lean mass was lower by 0.11 (-0.22, -0.001) kg per one serving of high-fat 
dairy, but associations were not observed among overweight [0.05(95% CI: -0.07 to 0.18) kg] or 
obese adults [0.02 ( 95% CI -0.16 to 0.20 kg)].  
Other dairy types were not significantly associated with BMI, nor any dairy products with any other 
anthropometric measure (Figures 2 and 3, Supplemental Figure 1).  
Other analyses 
Results were not altered when complete-case analyses were performed, and findings were similar 
when adjusting for the ratio of total energy intake to basal metabolic rate rather than adjusting for 
BMI or after further adjustment for dairy nutrients (Supplemental Table 3). There was no indication 
of a non-linear association from analyses with restricted cubic splines or categorical exposures after 
correction for multiple testing.  
Discussion 
Our study reports two main findings. The first was that habitual daily consumption of one serving 
of low-fat dairy products was associated with a 3% lower ratio of VAT to SCAT as a marker of fat 
mass distribution, a measure which is associated with diabetes risk independently of total fat 
mass(15). Second, habitual daily consumption of 1 serving of milk was associated with a 0.33 kg 
higher body lean mass. 
There are no previous studies on the association between dairy consumption and VAT/SCAT. A 
randomized controlled trial showed a reduction in VAT among those consuming 6-7 servings of 
dairy products per day compared to those consuming less than 4 servings/d(16), and a cross-
sectional study of twins reported an inverse association between low-fat fermented dairy products 
and VAT(17), but we have not identified any studies of the association between dairy consumption 
and SCAT. Although total dairy consumption has been consistently associated with a lower body 
fat mass in randomized controlled trials(31-33), the number of studies for dairy subtypes is limited. 
We found no significant associations between any dairy type and total or peripheral fat mass or 
waist circumference and waist-to-hip ratio as proxies for fat mass distribution. The direction of the 
associations we observed between low-fat dairy consumption and total body fat mass, and waist 
circumference was consistent with the findings of previous studies and with our findings for 
VAT/SCAT. The higher dairy amounts used in feeding trials compared to the consumption levels 
reported in observational studies could partly explain the lack of significance in certain associations. 
In addition, it is expected that the direction of the association of low-fat dairy products with 
VAT/SCAT is consistent with that of the association of low-fat dairy with waist circumference and 
the waist-to-hip ratio, because waist circumference is a proxy measure of abdominal fat. 
VAT/SCAT was estimated with higher accuracy than waist and hip circumferences. This might 
partly explain as to why the association with VAT/SCAT was significant after multiple test 
correction, but not the association with waist circumference and the waist-to-hip ratio.  
No mechanism has been reported for an inverse association between low-fat dairy consumption and 
VAT/SCAT. Nevertheless, a plausible explanation could be that VAT is more metabolically active 
with a more efficient glucose uptake than SCAT(34), and therefore the effects of dairy nutrients on 
fat mass are more pronounced in the VAT than in SCAT. Among dairy nutrients, calcium may 
reduce the fat content of the adipose tissue because intracellular calcium promotes lipolysis and 
reduces lipogenesis(35) and calcium supplementation was previously shown to decrease VAT 
without changing body weight or total abdominal fat(36).  
With our analyses and specifically the observed positive association between milk consumption and 
body lean mass, we extend the previous understanding on the positive association between total 
dairy consumption and total lean mass(31) to include specific dairy subtypes. Dairy products and 
mainly milk have been consistently associated with bone health due to their nutrients content 
including calcium, phosphorous, vitamin D and protein, which might partly explain the positive 
association with lean mass(37). Another potential mechanism is the increasing effect of milk on 
growth hormone(38, 39), which has been associated with a higher lean mass through a higher bone 
mineral density and muscle mass(40). 
Strengths and limitations 
Our study has several strengths including its large sample size (n=12,065), and the inclusion of 
several dairy subtypes, which allowed the investigation of potentially different associations with 
adiposity for different dairy types. By employing DEXA, we were able to use more accurate 
methods to assess VAT and SCAT than previous studies that used waist circumference and waist-
to-hip ratio as proxies of central adiposity(12). Our statistical approaches were thorough including 
the adjustment for important potential confounders including objectively measured physical 
activity, the derivation of estimates robust to outliers, and the handling of missing data with 
multiple imputation. 
Our study also has limitations. The cross-sectional design increases the risk of reverse causation and 
limits inference for causal association and our results can thus be used mainly for hypothesis 
generation. Although the food frequency questionnaire used was assessed for validity in a similar 
population(18) and we adjusted for BMI as an established factor of dietary misreporting(41), we 
cannot exclude the possibility of error due to dietary misreporting caused by the use of self-reported 
methods of dietary assessment. Commensurate with this, the food frequency questionnaire was 
limited in the detail on types of dairy products consumed, so we were not able to estimate the 
nutrient content accurately and thus made assumptions based on average estimates. The 
questionnaire also limited the assessment of various dairy definitions (e.g. sweetened yoghurt) and 
the influences of such variations on study results. Although we adjusted for many potential 
confounders, residual confounding cannot be ruled out. We were also not able to disentangle 
whether BMI was a confounder, a mediator or both in our cross-sectional analysis, while we could 
examine the associations independent of BMI. If BMI is on the causal pathway adjustment for BMI 
would have attenuated the findings towards the null. Future prospective analyses of change in 
weight (or BMI) in relation to dairy products will be better placed to investigate this further. The 
response rate of our study was moderate at 27%. This should be placed in the context of the internal 
validity of our study with our use of objective assessments i.e. DEXA on the full cohort, but we 
acknowledge limited external validity (generalisability) of our findings for the UK general 
population. Moreover, our population was largely white European, who overall consume higher 
amounts of dairy products compared to other populations especially in South Asia, South America 
and Africa (42), so generalisability of our results to other ethnic groups with different consumption 
patterns might be limited. Specifically, consumption of different dairy groups has a limited range in 
our study, with low levels of high-fat dairy products and high levels of low-fat dairy products. This 
might compromise the power to detect associations across a broader range of dairy consumption, 
which might be seen in other populations.  
Conclusion 
We observed an inverse association between low-fat dairy products and the ratio of visceral to 
subcutaneous fat, which suggests that abdominal obesity may be a potential pathway for the 
association of dairy consumption with cardio-metabolic disease. In addition, the observed 
association of higher milk consumption with a higher body lean mass could also be a potential 
explanation for the overall metabolic associations observed for dairy consumption. These findings 
are important for hypothesis-generation and should stimulate further investigation in prospective 
studies, clinical trials and mechanistic studies of the link between dairy products and 
cardiometabolic disease. 
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Table 1. Definitions of dairy groups (Fenland Study, 
UK) Dairy group Definition 
Full-fat milk Goat's milk; Channel Islands milk; Silver top full-cream milk; Evaporated milk whole diluted; Sheep's milk 
Low-fat milk Semi-skimmed milk; Skimmed milk; Skimmed milk as reconstituted dried milk 
Milk Full-fat milk, Low-fat milk 
Yoghurt Full-fat yoghurt
 
*; Low-fat yoghurt
 
* 
Cheese High-fat cheese
 †; Low-fat cheese ‡ 
Cream § Single cream; Double cream 
Low-fat fermented dairy products Total yoghurt; Low-fat cheese 
Fermented dairy products Total yoghurt; Total cheese 
High-fat dairy products Full-fat milk; High-fat cheese; Total cream; Butter; Ice-cream 
Low-fat dairy products Low-fat milk; Total yoghurt; Low-fat cheese 
Total dairy products Total milk; Total yoghurt; Total cheese; Total cream; Butter; Ice-cream 
*The variables derived directly from the FFQ questions were used
†The variable derived directly from the FFQ questions on hard cheese intake was used. The assumption made here is that high-fat cheese is equivalent to hard cheese. 
‡The variable derived directly from the FFQ questions on cottage and low-fat soft cheese intake was used. The assumption made here is that low-fat cheese is equivalent to cottage 
and low-fat, soft cheese. 
§Cream was used as a contributor to high-fat and total dairy products, but results separately for it and its types are not presented, as the very low intakes result in very unstable and
imprecise estimates 
Table 2. Descriptive characteristics  of socio-demographic, behavioural and clinical factors* for the bottom (non-consumers) and top categories of milk, yoghurt and cheese consumption (g/d), as well as in the total sample of 12,065 adults 
of the Fenland study, UK 
Milk
 † Yoghurt † Cheese † 
Median (IQR) 
consumption (g/d) 
Overall (%) 293  (146 - 439) 35.3 (8.8 - 71.8) 14.6 (4.8 - 26.9) 
0 g/d 585 - 732 g/d 0 g/d 99.5 - 1,134 g/d 0 g/d 26.8 - 284 g/d 
Participants (n) 12,065 921 1,490 2,787 3,014 779 3,028 
Socio-demographic 
factors 
Age (years) 48.8 (42.7-54.7) 49.6 (42.8-55.1) 48.0 (42.2–54.0) 48.6 (42.4-54.6) 50.0 (43.7-55.2) 48.8 (42.4-55.2) 48.1 (41.9-54.3) 
Sex (ref. Men): 
Women 
53.8 63.7 38.7 39.5 65.7 49.0 60.2 
Ethnicity ‡ (ref. 
White): Non-white 
2.9 4.9 1.4 3.3 1.8 7.9 1.6 
Educational level ‡
(ref. Low): Medium 
46.2 41.8 48.0 49.0 46.7 48.1 41.9 
High 33.9 40.7 27.5 25.0 33.5 23.9 42.1 
Age completing 
education (years) ‡ 
18.0 (16.0–21.0) 18.0 (16.0 – 22.0) 17.0 (16.0 – 21.0) 17.0 (16.0 – 20.0) 18.0 (16.0 – 21.0) 16.5 (16.0 – 19.0) 18.0 (16.0 – 22.0) 
Socio-economic 
status (based on 
occupation) §(ref. 
Low): Medium 
19.8 19.7 14.6 16.4 23.1 21.2 19.8 
High 53.3 58.3 47.6 46.1 52.5 42.7 58.4 
Income ‡  
(ref. <£20,000): 
£20,000 - 40,000 
35.4 32.6 37.5 37.8 37.3 38.5 34.4 
>£40,000 50.8 52.0 47.3 45.1 49.6 41.9 52.1 
Marital status ǁ 
 
(ref. Single): 
Married 
81.4 75.1 80.5 79.9 80.8 77.1 80.2 
Widowed /Separated 9.5 10.3 9.9 9.3 10.3 9.6 9.8 
Lifestyle factors 
Smoking status  ‡ 
(ref. Never): Former 
33.3 35.6 31.8 32.0 34.0 27.6 34.3 
Current 12.3 13.3 17.8 20.1 7.6 13.5 11.1 
Smoking (pack-
years) § 
0.0 (0.0 - 2,376) 0.0   (0.0 - 2,696) 0.0 (0.0 - 3,701) 0.0 (0.0 - 4,362) 0.0  (0.0 - 1,414) 0 .0 (0.0 - 2,725) 0 .0 (0.0 - 2,192) 
Physical activity 
energy expenditure 
(kJ/kg per d) ‡ ¶ 
50.7 (37.6 - 66.5) 49.9 (38.1 - 63.5) 55.4 (40.8 - 72.4) 51.2 (37.7 - 67.8) 50.5 (37.0 - 65.4) 49.4 (35.7 - 65.7) 52.0 (38.8 - 67.6) 
Energy intake (kJ/d) 1,851  (1,524 - 2,265) 1,600  (1,312 - 2,030) 2,140  (1,733 - 2,613) 1,768  (1,433 - 2,180) 1,932  (1,603 - 2,345) 1,681  (1,360 - 2,081) 2,067  (1,691 - 2,507) 
BMI (kg/m
2
) 26.2 (23.6 - 29.4) 25.8 (23.0 - 29.1) 26.7 (24.2 - 29.9) 26.6 (23.8 - 29.6) 26.1 (23.5 - 29.3) 26.5 (23.8 - 29.6) 25.8 (23.2 - 29.1) 
Medications / 
Supplements 
Lipid-lowering  
medication ‡ (ref. 
No): Yes 
4.0 4.0 3.0 4.7 4.0 4.4 3.3 
Anti-hypertensive 
medication
 ‡ (ref. 
No): Yes 
7.4 7.4 6.3 8.2 7.1 7.8 6.9 
Hormonal therapy ‡ 2.8 3.4 1.9 2.0 3.5 2.7 3.2 
(ref. No for women / 
Men): Yes 
Dietary supplements 
‡ (ref. No): Yes 
41.2 49.5 40.5 33.5 47.7 39.5 44.5 
IQR, Interquartile range 
*Continuous variables are presented as median (IQR) and categorical variables are presented as column percentages
†Five categories; Milk: Non-consumers, 146 g/d, 293 g/d, 439 g/d, 585 or 732 g/d (categories presented: non-consumers and 585-732 g/d); Yoghurt: Non-consumers and quartiles within consumers (1st quartile:8.8-8.8 g/d, 2nd quartile: 17.6 
– 35.3 g/d, 3rd quartile: 54.2 – 71.8 g/d, 4th quartile: 99.5 – 1,134 g/d ;categories presented: non-consumers and 4th quartile within consumers); Cheese: Non-consumers and quartiles within consumers (1st quartile: 2.4 – 4.8 g/d, 2nd quartile:
6.6 – 13.2 g/d, 3rd quartile: 14.6 – 25.8 g/d, 4th quartile: 26.8 – 284.6 g/d; categories presented: non-consumers and 4th quartile within consumers). Dairy consumption was assessed with a food frequency questionnaire Milk consumption 
was assessed with two questions. In the first question, participants could choose the type of milk that they consumed most frequently (options: “Full cream, silver”, “Semi-skimmed, red/white”, “Skimmed/blue”, “Channel Islands, gold”, 
“Dried milk, “Soya”, “Other”, “None”). In  the second question, participants could choose one of six categories for the daily amount of milk consumed [options: “None”, “Quarter of a pint” (146 g/d), “Half a pint” (293 g/d), “Three 
quarters of a pint” (439 g/d), “One pint” (585 g/d), “More than one pint” (732 g/d)]. Full-fat yoghurt, low-fat yoghurt, high-fat cheese, low-fat cheese, butter, cream and ice-cream were assessed with questions including nine frequencies, 
which ranged from “Never or less than once/month” to “6+ per day”.  
‡Percentage of missing values < 5% with a total of 28.8% of missing values when accounting for non-overlapping missing values across all the variables  
§Percentage of missing values 5-15% with a total of 28.8% of missing values when accounting for non-overlapping missing values across all the variables
ǁPercentage of missing values 15-25% with a total of 28.8% of missing values when accounting for non-overlapping missing values across all the variables 
¶ Physical activity was objectively measured with a combined heart rate and movement sensor.  
Figure 1. Participant selection for analyses of associations of dairy consumption with cardio-
metabolic markers in over 12,000 adults of the Fenland Study, UK. *A minimal number of 
participants for each sub-group of the outcomes is presented. Numbers slightly varied depending on 
missing information of each outcome variable.  
Figure 2. Associations of types of dairy consumption (servings/d) with markers of body 
composition estimated with dual energy X-ray absorptiometry (DEXA) among over 12,000 adults 
in the Fenland Study, UK.  Forest plots represent regression coefficients with their 95% CIs 
adjusted for age (years), sex, test-site (Cambridge, Ely, Wisbech), ethnicity (white, non-white), total 
energy intake (kcal/d), other dairy types, educational level (low, medium, high), age when full-time 
education finished (years), socio-economic status based on occupation (low, medium, high), income 
(<£20,000, £20,000-40,000, >£40,000), marital status (single, married, widowed/separated), 
smoking status (never, former, current smoker), pack-years of smoking, energy expenditure due to 
physical activity (kJ/kg per d), lipid-lowering medication (yes/no), anti-hypertensive medication 
(yes/no), hormone-replacement therapy (yes/no in women), intakes (g/d) of fruit, vegetables, 
potatoes, legumes, processed cereals, whole-grain cereals, poultry and eggs, red meat, processed 
meat, fish, sauces, margarine, nuts, sweet snacks, sugar-sweetened beverages, artificially sweetened 
beverages, fruit juice, regular coffee, decaffeinated coffee, tea and alcoholic beverages, plasma 
vitamin C levels (µmol/l), dietary supplement use (Yes, No), and BMI (kg/m
2
). Statistically 
significant associations after false discovery rate corrections are marked with an asterisk.  See 
categorisation of dairy types in Table 1. DEXA: Dual Energy X-ray Absorptiometry; SCAT: 
Subcutaneous Adipose Tissue; VAT: Visceral Adipose Tissue 
Figure 3. Associations of types of dairy consumption (servings/d) with waist circumference and the 
waist-to-hip ratio among over 12,000 adults in the Fenland Study, UK.  Forest plots represent 
regression coefficients with their 95% CIs adjusted for age (years), sex, test-site (Cambridge, Ely, 
Wisbech), ethnicity (white, non-white), total energy intake (kcal/d), other dairy types, educational 
level (low, medium, high), age when full-time education finished (years), socio-economic status 
based on occupation (low, medium, high), income (<£20,000, £20,000-40,000, >£40,000), marital 
status (single, married, widowed/separated), smoking status (never, former, current smoker), pack-
years of smoking, energy expenditure due to physical activity (kJ/kg per d), lipid-lowering 
medication (yes/no), anti-hypertensive medication (yes/no), hormone-replacement therapy (yes/no 
in women), intakes (g/d) of fruit, vegetables, potatoes, legumes, processed cereals, whole-grain 
cereals, poultry and eggs, red meat, processed meat, fish, sauces, margarine, nuts, sweet snacks, 
sugar-sweetened beverages, artificially sweetened beverages, fruit juice, regular coffee, 
decaffeinated coffee, tea and alcoholic beverages, plasma vitamin C levels (µmol/l), dietary 
supplement use (yes/no), and BMI (kg/m
2
). Statistically significant associations after false 
discovery rate corrections are marked with an asterisk. See categorisation of dairy types in Table 1.  
